Upload
noah-cummings
View
214
Download
0
Tags:
Embed Size (px)
Citation preview
Advances in Continuous Renal Replacement Therapy
CSM 2011Dr Anne Leung17th May 2011
Overview
DOSE
Fluid and anticoagulatio
n
Timing of initiation
Membrane
To begin the “Dosing” story of CRRT….
20mL/Kg/hr 35mL/Kg/hr 45mL/Kg/hr
15-days Survival
41% 57% 58% Lancet 2000
Higher the dose the better
EIHF vs Conventional 45mL/Kg/hr for 6 hours then 20mL/Kg/hr vs 20mL/Kg/hr
28-day Survival: 55% vs 27.5%
Piccinni ICM 2006
CVVHDF: more may not be better
PRCT
Single Center
N=200
Pre-dilution
CVVHDF: 20mL/Kg/HrCVVDHF: 35mL/Kg/Hr
Tolwani et al JASN 2008
Intense Conventional
Hemodynamic stable
IHD /SLED 6x/week with Kt/V of 1.2-1.4
IHD /SLED 3x/week with Kt/V of 1.2-1.4
Hemodynamic unstable
CVVHDF 35mL/Kg/Hr
CVVHDF 20mL/Kg/Hr
Intensive RRT = Equal ATN trial
PRCT
N=1124
60 days mortalityIntensive: 53.6%
Less Intensive: 51.5%
What Dose ?
• Before the ATN trial• CRRT: 35mL/Kg/Hr• Daily iHD
• After the ATN trial• SOFA 0-2: 3x/week iHD (Kt/V 1.2)• SOFA 3-4: CRRT 20 mL/Kg/hr or SLED 3x/week• But beware for the need for extra treatment!
Randomized(Post-dilution CVVH)
1508
Low dose(25ml/Kg/hr)
761
High dose(40ml/Kg/hr)
747
Lost to follow up = 1Consent withdrawn = 2
Consent not obtained = 23
Analyzed722
Lost to follow-up = 0Consent withdrawn = 2
Consent not obtained = 16
Analyzed743
RENAL Study
High Intensity
Low Intensity
90-days mortality 44.7% 44.7%
28-days mortality 38.5% 36.5%
Conclusion• Intensity of RRT DOES matter
• Beyond the threshold dose ( 25ml/kg/hr), increasing intensity does not provide further clinical benefit
• Be-aware of the difference between prescribed and delivered dose of RRT• ATN study: 89% -95% • RENAL study: 84-88%
• Minimize the interruption of the treatment time
IVOIRE (hIgh Volume in Intensive Care)—French Study• Inclusion criteria: Septic shock <24 hrs and RIFLE
criteria of injury or worse
• Intervention: High volume (70ml/kg/hr) vs Standard (35ml/Kg/hr) for 96 hours
• Patient number: total of 460 patients
• Primary outcome: 28-day mortality
• Study period: 3 years and completed by Oct 2010
INITIATION OF THERAPY
RIFLE Criteria
Currr Opin Crit Care 8: 509-514 (2002)
Level of injury
Outcome measure
s
From RIFLE to AKINSerum
Creatinine
Increase SCr ≥24.6mmol/L
2-3 folds
Stage 1
Stage 2
Stage 3
The Acute Kidney Injury Network Classification ( AKIN)
Crti Care 11:R31 (2007)
Biomarkers of AKI
uNGAL Serum Cystatin C
MEMBRANE OF FILTER
Super High-Flux or High Cut-ff Membranes
Achieve greater clearance of inflammatory cytokines
- Superior elimination of IL-6- Decrease need of Nor-
adrenaline over time
P.
20
SepteX—High Cut Off Membrane
Pilot Randomized Controlled Study Comparing the Effect of High Cut-off Point Hemofiltration with Standard Hemofiltration in Patient with Acute Renal Failure• Study Population:
• Critically ill patient with AKI and shock that require Nor-adrenaline
• Intervention: • Standard polyamide high flux membrane vs High cut-off
polyamide membrane (P2SH)• CVVH: Qb: 200ml/min, UF of 25ml/Kg/hr
• Size of the study: • 72 patients
• Primary measures• NA-free time in first week after randomization
• Status: • start in Jun 2009 and still recruiting
P.
22
Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock--The EUPHAS Randomized controlled Trial JAMA 2009
Polymyxin B immobilized fiberDirect Hemo-Perfusion
Early Use of Polymyxin B Hemoperfusion in Abdominal sepsis
Decrease vasopressor requirement
Better BP and low SOFA score
Mortality of 32 % vs 53%
FLUID & ANTICOAGULANT
Continuous renal replacement therapy: B.E.S.T. Kidney (The Beginning and Ending Supportive Therapy for the kidney).
a worldwide practice survey. 23 Countries, 54 ICUs, 1006 patients with ARF on CRRT
UFH43%
No anticoagulant33%
Citrate10%
LMWH4%
Nafamostat6%
Others4%
Intensive Care Med. 2007;33(9):1563-70
Less clotting in Hollow Fibers membrane Kid Int 1999
Commercial preparation of citrate
solution—Morgera S. et al .CCM 2009
Gp 1 (60Kg)
Gp 2 (60-90Kg)
Gp 3 (>90Kg)
Patient No 19 97 45Blood flow(mL/min)
80 100 120
Dialysate flow (mL/hr)
1500 2000 2500
Citrate flow( mL/hr)
140 170 205
A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status—CCM 2009
• Result• Median filter time of
61.5 hrs• 5% had filter clot• Excellent control of
acid-base and electrolyte
Use of citrate CVVH was safer and reduced mortality Oudemans MH et al CCM 37:545-552 ( 2009)
Hospital mortality 41 vs 57% (p=0.03)3-month Mortality 45 vs 62% (p=0.02)
CCM 37: 545 - 552 ( 2009)
Surgical
Sepsis Higher SOFA Younger than 73
Negative Fluid Balance Predicts Survival in Patients with Septic Shock--Alsous F. et al Chest 2000
3 5 6 72 41
Net negative fluid balance within first
3 days in ICU
100% 20%
The Importance of Fluid Management in Acute Lung Injury Secondary to Septic Shock— Murphy CB et al Chest 2009
3 5 6 72 41
20ml/Kg with CVP≥8 within 4 hrs after
vasopressorsNeutral or negative fluid for 2 consecutive days during
first 7 days
Hospital mortality of
18.3%
The Importance of Fluid Management in Acute Lung Injury Secondary to Septic Shock— Murphy CB et al Chest 2009
3 5 6 72 41
20ml/Kg with CVP≥8 within 4 hrs after
vasopressorsNeutral or negative fluid for 2 consecutive days during
first 7 days
Hospital mortality of 77.1%
3 5 6 72 41
Survivor:Fluid balance non-positive
by D4
Sepsis in European Intensive Care Units: Results of the SOFA study— JL Vincent et al 2006;344-353
3 5 6 72 41
Cumulative fluid balance within 72 hrs after onset of
sepsis was independent predictor of
mortality
10% increase in mortality with each 1L increase in cumulative fluid balance
Comparison of Two Fluid-Management Strategies in Acute Lung Injury— NEJM 2006
3 5 6 72 41
Conservative fluid mx
-higher ventilator-free and ICU free days
-Less cardiovascular failure
-Less on dialysisConservative group: zero balance by D4
Fluid Accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury— (PICARD study)Bouchard J et al KI 2009id removal
Fluid overload patient tended to be sicker patient
No Fluid overload
Fluid overload
APACHE III score
79 90
SOFA score 6.7 8.7No of organ failure
2.6 3.2
Resp failure 55% 86%On ventilator
32% 65%
Sepsis/Septic shock
22% 39%
For each weight change class, fluid overload is independent predictor of
mortality
? “Fluid” as the AKI biomarker
USE OF RCA IN QEH ICU
If I find 10,000 ways something won't work, I haven't failed. I am not discouraged, because every wrong attempt discarded is often a step forward....Thomas Edison
Citrate doseCitric Acid
mmol/L
Sodium Citrate
mmol/L
Complementary solution Therapy BFRmL/min
Citrate dose(mmol/L blood)
Country
Apsner 5 10 - CVVH 100 3.7 Austria
Dorval / Leblanc 5 15 Dia: 0.9% Saline (if needed) CVVH(DF) 125 3.7 Canada
Niles - 13.3 - CVVH 180 2.0 USA
Gabutti - 13.3 Dialysate same as citrate CVVH(DF) 125 2.66 Switzerland
Tolwani - 2% 0.9% Saline CVVHD 150 2.0 USA
Sramek - 2.2% Na=120, Bicar=22 CVVHDF 100 3.6 - 6.3 Czech Republic
Bunchman ACD-A Dia: Normocarb CVVHD(F) 150 2.8 USA
Chadha ACD-A Pre: Na=140, Bicar=20 CVVH 50 - 150 1.9 - 4.2 USA
Mitchell / Heemann ACD-A Calcium in dialysate CVVHD 75 5.7 - 8.5 Germany
Gupta ACD-A Calcium in dialysate CVVHDF 150 1.9 USA
Cointault ACD-A Calcium in dialysate & pre CVVHDF 125 3.9 France
Kustogiannis / Gibney - 3.9% Dia: Na=110, Bicar=variable CVVHDF 125 3.6 Canada
Mehta - 4% Dia: Na=117, Bicar=0 CVVHD(F) 100 3.7 - 5.9 USA
Hoffmann - 4% Pre: 0.9% Saline CVVH 125 3.1 USA
Monchi - 1000 Post: Na=120 , Bicar=0 CVVH 150 4.3 France
Evenepoel - 1035 Calcium in dialysate IHD 300 4.3 Belgium
Who can do that ?
PYNEH ICU (1995-2003)
AK 10 machine
Non-integrated approach
Ci-Ca Dialysate solution
Solution for RCA--Gambro
PYNEH ICU ( 2004 …..
RCA CRRT—QEH Regime
RCA CRRT—QEH Regime
RCA CRRT—QEH Regime
CaCl2 infusion
Summary of the regime• Machine: Prismaflex
• Pre-dilution with Primocitrate 10/2 at rate of 2500mL/hr
• Blood flow at 150ml/min
• Both UF and blood flow rate fixed
• Separate infusion of NaHCO3 ( initial 50ml/hr for 2 hr then 30ml/hr ) and Calcium chloride infusion via CVC at 6 ml/hr
• For fluid removal= desired fluid removal + flowrate of NaHCO3
• Measure Na, K, BE, ABG and ionized calcium Q4-6 hr
• Target ionized calcium 0.9 – 1.3 mmol/L
Implementation• Theory Session
• For both nurses and doctors
• Practical Session• By Gambro in early March
• Guideline as the reference
• Case selection• Avoid those with liver dysfunction, after massive transfusion and
severe metabolic acidosis with pH<7.1• Start with post-op case with mild to moderate acidosis and fluid
problems• Start during the daytime• Gambro technical support stand-by during the initial phase
• Trouble shooting• Contact Dr Anne Leung
• Mechanism of action
• Exclusion criteria
• Set up of the citrate circuit
• Monitoring during RCA
• Titration of electrolyte and acid-base
• Citrate toxicity
7th Jul 2010
Demographic data
Reasons for admission for CRRT
How long the circuit last?
Mean duration ( hr) 31.4±14.4
Maximum duration( hr) 62.3
Minimum duration ( hr) 5.2
Circuit time
Number of episode
Percentage
24 hrs 23 41%
>24% 33 59%
>48% 9 16%
Reasons for termination CRRT
Last from 22 to 49.5 hrs
-5 due to procedures-3 due to nursing manpower restrain
Electrolyte disturbance during Citrate CVVH
Only 2 patients had citrate accumulation
Only 2 patients with Total Ca/iCa >2.5
had citrate accumulation
Rate of correction of metabolic acidosis
Median BE o f-4.5 and it took 20 hrs to reach the median BE of 0
Cases of citrate accumulation Circuit
time(hr)Base Excess changes over time
Anion Gap
Total Ca/iC
a
Bil(start)
Baseline BE 4hrs 8 hrs 12 hrs 16 hrs 20 hrs 24 hrs Case 1 9.6 -12 -6 -8 -10 29 4.1 27
Case 2 24 -3 -5 -3 -3 -5 -4 -1.2 27 2.87 61
Case 3 9.8 -17 -15 -16 32 2.4 54
Case 4 25 -14 -11 -11 -13 -15 36 2.46 5
Onset:10 to 25 hours after commencement of therapy
Lab data suggesting citrate accumulation: slow correction of metabolic acidosis or worsening of control of metabolic acidosis Confirmation:Increased anion gap;High Total Ca/iCa >2.5 and Spontaneous correction of metabolic acidosis after stopping the therapy
ICU and Hospital outcome
ICU mortality of 23% Hospital mortality of 54.5%
"Genius is one per cent inspiration and ninety-nine per cent perspiration. Accordingly, a 'genius' is often merely a talented person who has done all of his or her homework."
--Thomas Edison